Teclistamab
A Study of Outpatient Administration of Teclistamab, a BCMA-targeting Bispecific Antibody, in Multiple Myeloma Patients
Filters
Save & Share
Clear Filters
Location
Explore options near your patient - or anywhere in the US.
Diagnosis
Treatment History
BCMA Therapy
This stands for B Cell Maturation Antigen (BCMA) and includes treatments such as ide-cel, cilta-cel or belantamab mafodotin.
Near Add Your Location
Sort by
Rocky Mountain Cancer Centers (Midtown)
Denver, CO
- Accepting patients
Oncology Associates of Oregon
Eugene, OR
- Accepting patients
- Accepting patients
Colorado Blood Cancer Institute
Sarah Cannon at Presbyterian/St. Luke's Medical Center (HealthONE)
Denver, CO
- Accepting patients
Oncology Hematology Care, Inc. - Blue Ash
Cincinnati, OH
- Accepting patients
Arizona Oncology Associates
Tucson, AZ
- Accepting patients
- Accepting patients
Maryland Oncology Hematology (Columbia)
Columbia, MD
- Accepting patients
- Accepting patients
Texas Oncology - San Antonio Medical Center
San Antonio, TX
- Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.